ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Cancer Genetics
Latest Publications
TOTAL DOCUMENTS
1675
(FIVE YEARS 440)
H-INDEX
43
(FIVE YEARS 6)
Published By Elsevier
2210-7762
Latest Documents
Most Cited Documents
Contributed Authors
Related Sources
Related Keywords
Latest Documents
Most Cited Documents
Contributed Authors
Related Sources
Related Keywords
Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome
Cancer Genetics
◽
10.1016/j.cancergen.2022.01.001
◽
2022
◽
Author(s):
Annie Garcia
◽
Lauren Desrosiers
◽
Sarah Scollon
◽
Stephanie Gruner
◽
Jacquelyn Reuther
◽
...
Keyword(s):
Leydig Cell
◽
Hotspot Mutations
◽
Dicer1 Syndrome
◽
Leydig Cell Tumors
Download Full-text
Editorial Board
Cancer Genetics
◽
10.1016/s2210-7762(21)00245-3
◽
2022
◽
Vol 260-261
◽
pp. ii
Download Full-text
Pan-tumor screening for NTRK gene fusions using pan-TRK immunohistochemistry and RNA NGS fusion panel testing
Cancer Genetics
◽
10.1016/j.cancergen.2021.12.010
◽
2022
◽
Author(s):
Anne K. Koehne de González
◽
Mahesh M Mansukhani
◽
Helen Fernandes
◽
Susan J Hsiao
Keyword(s):
Gene Fusions
◽
Panel Testing
Download Full-text
Evaluation of DNA methylation in promoter regions of hTERT, TWIST1, VIM and NID2 genes in Moroccan bladder cancer patients.
Cancer Genetics
◽
10.1016/j.cancergen.2021.12.001
◽
2021
◽
Author(s):
Meryem El Azzouzi
◽
Hajar El Ahanidi
◽
Chaimae Hafidi Alaoui
◽
Imane Chaoui
◽
Laila Benbacer
◽
...
Keyword(s):
Dna Methylation
◽
Bladder Cancer
◽
Cancer Patients
◽
Promoter Regions
Download Full-text
A Founder CHEK2 Pathogenic Variant in Association with Kidney Cancer
Cancer Genetics
◽
10.1016/j.cancergen.2021.12.007
◽
2021
◽
Author(s):
Kassi Brooks
◽
Melissa Holman
◽
Catherine Steding
◽
Megan Tucker
Keyword(s):
Kidney Cancer
◽
Pathogenic Variant
Download Full-text
Diagnostic testing approaches for the identification of patients with TRK fusion cancer prior to enrollment in clinical trials investigating larotrectinib
Cancer Genetics
◽
10.1016/j.cancergen.2021.11.006
◽
2021
◽
Author(s):
Erin R. Rudzinski
◽
Jaclyn Hechtman
◽
Sinchita Roy-Chowdhuri
◽
Marion Rudolph
◽
Christina M. Lockwood
◽
...
Keyword(s):
Clinical Trials
◽
Diagnostic Testing
Download Full-text
A complex KMT2A::AFF3 fusion resulting from a three-way chromosomal rearrangement in pediatric B lymphoblastic leukemia
Cancer Genetics
◽
10.1016/j.cancergen.2021.12.005
◽
2021
◽
Author(s):
Lauren J. Miller
◽
Vasiliki Leventaki
◽
Paul D. Harker-Murray
◽
Holli M. Drendel
◽
Kathleen M. Bone
Keyword(s):
Chromosomal Rearrangement
◽
Lymphoblastic Leukemia
Download Full-text
Acute myeloid leukemia with t(X;6)9p11;q23);MYB-GATA1 and female sex: GATA1 insufficiency may be insufficient for pathogenesis
Cancer Genetics
◽
10.1016/j.cancergen.2021.11.007
◽
2021
◽
Author(s):
Alexandra E. Kovach
◽
Elena Zerkalenkova
◽
Ludmila Zemtsova
◽
Aleksandra Borkovskaya
◽
Marina Gaskova
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
Myeloid Leukemia
◽
Female Sex
◽
Acute Myeloid
Download Full-text
Is 5q deletion in de novo Acute Myelogenous Leukemia (AML) with excess blasts a surrogate marker for the cryptic t(7;21)(p22;q22)? A case report and review of literature.
Cancer Genetics
◽
10.1016/j.cancergen.2021.12.008
◽
2021
◽
Author(s):
Robert D. Johnston
◽
Farzaneh H. Sayedian
◽
Christina Mendiola
◽
William Ehman
◽
Veronica Ortega
◽
...
Keyword(s):
Case Report
◽
Acute Myelogenous Leukemia
◽
De Novo
◽
Surrogate Marker
◽
Myelogenous Leukemia
◽
Review Of Literature
◽
Acute Myelogenous
◽
5Q Deletion
Download Full-text
NTRK Point Mutations and Their Functional Consequences
Cancer Genetics
◽
10.1016/j.cancergen.2021.12.002
◽
2021
◽
Author(s):
Corey Rogers
◽
Jennifer J.D. Morrissette
◽
Robyn Sussman
Keyword(s):
Point Mutations
◽
Functional Consequences
Download Full-text
Load More ...
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close